You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 6, June 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  This Month in Archives of General Psychiatry
 This Article
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

This Month in Archives of General Psychiatry

Arch Gen Psychiatry. 2009;66(6):579.

King et al (SEE ARTICLE) report the primary outcomes of a 12-week study that examined whether citalopram hydrobromide is effective for the treatment of repetitive behavior in autism. Citalopram was no better than placebo on measures of overall improvement or repetitive behavior. Adverse effects, such as hyperactivity, insomnia, and impulsivity, were more common in the citalopram group compared with placebo.

In a large sample of subjects with schizophrenia, McGrath et al (SEE ARTICLE) factor analyzed not only symptom and prodrome indicators but also indicators of function in child, adolescent, and adult periods. Nine factors covered traditional (hallucinations, negative, disorganized, affective, Schneiderian first-rank) as well as novel domains (scholastic, child/adolescent sociability, prodromal, and disability/impairment). Factor scores in all domains demonstrated significant familiality, offering a range of phenotypes for genetic analyses.

Most of the antipsychotics in clinical practice have equivalent in vitro affinity for the dopamine D2 and D3 receptors. Using the D3 receptor–preferential positron emission tomography radioligand [11C]-(+)-PHNO [carbon 11–labeled (+)-4-propyl-9-hydroxynaphthoxazine], Graff-Guerrero et al (SEE ARTICLE) report that long-term antipsychotic treatment including clozapine, olanzapine, or risperidone in schizophrenia is not associated with D3 receptor blockade despite the ongoing D2 receptor blockade.

The association between depression and hypothalamic-pituitary-adrenal axis activity was examined by Vreeburg et al (SEE ARTICLE) in the Netherlands Study of Depression and Anxiety. As compared with 308 controls, a higher salivary cortisol awakening response was found in 579 persons with remitted and 701 with current major depressive disorder. These findings confirm modest but significantly increased hypothalamic-pituitary-adrenal axis activity among depressed individuals, possibly indicative of an underlying biological vulnerability for depression.

People change place of residence often in contemporary society, which might induce hardship and distress to children and adolescents. Using data from Danish longitudinal registries to include all children born in 1978 to 1995, Qin et al (SEE ARTICLE) provide evidence on how frequent change of residence is associated with risk for attempted and completed suicide among children and adolescents, indicating a likely dose-response relationship.

Libby et al (SEE ARTICLE) show that the unintended declines in depression care persisted after the Food and Drug Administration's October 2003 advisory about the risk of suicidality for pediatric patients taking antidepressants and 2005 boxed warning (later extended to include young adults). Through June 2007, reductions in primary care and psychiatry case finding and non–selective serotonin reuptake inhibitor substitute treatment continued for pediatric and young adult patients, as well as adult patients (not targeted by the warnings).

Hicks et al (SEE ARTICLE) used a sample of 1315 adolescent twin pairs to examine gene x environment interactions between externalizing disorders (antisocial behavior and substance abuse) and 6 environmental risk factors (measures of peer, family, and school environments). For each environmental risk factor, a significant gene x environment interaction was detected, such that in the context of environmental adversity, genetic factors became more important in the etiology of externalizing disorders.

Dick et al (SEE ARTICLE) report analyses aimed at characterizing the pathway of risk associated with GABRA2, a gene previously associated with adult alcohol dependence, in a community sample of children, followed up longitudinally from childhood through young adulthood. GABRA2 was associated with persistent, elevated trajectories of externalizing behavior. A significant interaction with parental monitoring emerged whereby the association of GABRA2 with externalizing trajectories was diminished under higher parental monitoring.

Traumatic experiences during childhood are associated with increased risk for developing stress-related neuropsychiatric disorders in later life in humans. To identify brain structural differences that may predict such disorders, Spinelli et al (SEE ARTICLE) used structural magnetic resonance imaging in monkeys raised either with their mothers or with 3 age-matched animals. An established stress cortex was found in peer-reared compared with mother-reared monkeys, suggesting an increased vulnerability of these regions.

Using single-photon emission computed tomography brain imaging, Cosgrove et al (SEE ARTICLE) found that tobacco smoking induced increases in available levels of nicotinic acetylcholine receptors containing the β2 subunit that decrease during prolonged abstinence (eg, 4-12 weeks) from tobacco smoking. These marked and persistent changes in receptor availability may contribute to difficulties with tobacco smoking cessation.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.